Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lung

Keyphrases

• Alpha-1 Antitrypsin Deficiency 100%
• Area Cover 50%
• Augmentation Therapy 100%
• Chronic Obstructive Pulmonary Disease 50%
• Cirrhosis 50%
• Clinical Features 50%
• Cochrane Library 50%
• Disease Progression 50%
• Early Onset 50%
• Effective Treatment 50%
• Embase 50%
• Emphysema 50%
• Expert Opinion 50%
• Gene Therapy 50%
• Global Practice 50%
• Hepatocytes 50%
• Hereditary Disease 50%
• Inflammation 50%
• Literature Search 50%
• Liver Cirrhosis 50%
• Liver Disease 50%
• Lung 100%
• Lung Disease 100%
• MEDLINE 50%
• Misfolding 50%
• Molecular Pathways 50%
• Multisystem Disease 100%
• Ovid 50%
• Panniculitis 50%
• Pathophysiology 50%
• Randomized Clinical Trial 50%
• Replacement Therapy 50%
• Slow Progression 50%
• Stem Cells 50%
• Treatment Modalities 50%
• Z Allele 50%

Medicine and Dentistry

• Allele 50%
• Alpha 1-Antitrypsin Deficiency 100%
• Alpha Antitrypsin Deficiency 50%
• Chronic Obstructive Pulmonary Disease 50%
• Clinical Feature 50%
• Disease Exacerbation 50%
• Emphysema 50%
• Gene Therapy 50%
• Genetic Disorder 50%
• Hepatocyte 50%
• Liver Cirrhosis 100%
• Liver Disease 50%
• Lung 100%
• Lupus Erythematosus Panniculitis 50%
• Pathophysiology 50%
• Randomized Clinical Trial 50%
• Silo-Filler's Disease 100%
• Stem Cell 50%
• Substitution Therapy 50%
• Systemic Disease 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha 1 Antitrypsin Deficiency 100%
• Alpha Antitrypsin Deficiency 50%
• Chronic Obstructive Lung Disease 50%
• Clinical Feature 50%
• Disease Exacerbation 50%
• Emphysema 50%
• Genetic Disorder 50%
• Inflammation 50%
• Liver Cirrhosis 100%
• Liver Disease 50%
• Lung Disease 100%
• Panniculitis 50%
• Pathophysiology 50%
• Randomized Clinical Trial 50%
• Replacement Therapy 50%
• Systemic Disease 100%